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Helicobacter Pylori-induced STAT3 Activation and Signalling 
Network in Gastric Cancer
Junhong Zhao, Yujuan Dong, Wei Kang, Ka Fai To, Joseph JY 
Sung, Jun Yu
Institute of Digestive Disease and Department of Medicine and 
Therapeutics, State Key Laboratory of Digestive Disease, Li Ka 
Shing Institute of Health Sciences, The Chinese University of 
Hong Kong, Hong Kong
Background: Helicobacter pylori (H. pylori) is the most important 
gastric carcinogen. However, the mechanisms of H. pylori 
induced gastric carcinogenesis through STAT3 activation are 
largely unknown. We evaluated the effects of H. pylori infection on 
STAT3 activation and dissected the signalling network of STAT3 
in H. pylori-infected gastric carcinogenesis.
Methods: The expression of phospho-STAT3 (pSTAT3) was 
evaluated by immunohistochemistry and western blot. Gene 
expression array and chromatin immunoprecipitation were used 
to dissect the STAT3 signalling network on H. pylori co-cultured 
AGS.
Results: The STAT3 activation (pSTAT3) was significantly 
higher in H. pylori-positive gastritis (73.5%, 61/83) than in H. 
pylori-negative gastritis (50%, 35/70) (P = 0.003). In addition, 
98% (43/44) of H. pylori positive intestinal metaplasia specimens 
showed STAT3 activation, whereas pSTAT3 was significantly 
decreased in all 43 specimens one year after H. pylori 
eradication (P < 0.001). Moreover, pSTAT3 was only detected 
in the H. pylori-infected gastric tissues of mice but not in control 
mice, providing direct evidence that H. pylori infection stimulated 
the activation of STAT3 in the stomach. By comparing the 
gene expression profiles, we identified a total of 849 aberrant 
expression genes enriched in 11 cancer pathways in H. pylori 
induced STAT3 activation in gastric cancer cells. We further 
identified 6 candidates (BRUNOL4, FGFR1, SHOX2, JAK3, 
MAPK8, and PDPN) were directly up-regulated by H. pylori 
induced STAT3 activation.
Conclusions: H. pylori infection triggers the activation of STAT3 
and de-regulates multitude of tumorigenic genes which may 
contribute to the initiation and progression of gastric cancer.
Ref. No.: 10090942
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Role of Toll-like Receptors in Naturally Occurring Influenza
Nelson Lee, CK Wong, Martin Chan, Paul KS Chan
The Chinese University of Hong Kong, Hong Kong
Background: We investigated the roles of Toll-like receptors 
(TLRs) in naturally occurring influenza.
Methods: A prospective, case-control study was conducted. 
Adults hospitalized with virologically confirmed influenza A 
infections (onset <48 hours, before treatment) were compared 
with age-/gender-matched controls. TLRs (2, 3, 4, 7, 8, 9) 
expression in monocytes and dendritic cells (DCs - total, myeloid, 
plasmacytoid) was quantitated using flow cytometry. Gene 
expression of RLRs (RIG-1, MDA-5) was evaluated using real-
time PCR. Concomitant signaling molecules expression, plasma 
cytokine/chemokine concentrations, and respiratory tract viral 
loads were measured. PBMCs were cultured and stimulated ex 
vivo with TLR-specific ligands for cytokine responses.
Results: Forty two patients with influenza (24 A/H3N2, 18 A/
H1N1pdm09) and 20 controls were studied. Patients' mean 
age was 68 16 years; 81% had respiratory/cardiovascular 
complications. There were increased cellular expressions of 
TLR9, TLR8, TLR3, and TLR7 during influenza; TLR2 and TLR4 
were suppressed. Results were similar for both virus strains. 
Higher TLR expression levels at presentation significantly 
correlated with lower viral loads (Spearman's rho: 046 to 069 for 
TLR9, TLR8, and TLR3; P-values <005). Multivariate regression 
models (adjusted for age, comorbidity, disease severity, time 
from onset) confirmed their independent associations. Increased 
signaling molecules (phospho-MAPKs, IkB) and inflammatory 
cytokines (IL-6, sTNFR-1, CCL2/MCP-1; CXCL10/IP-10, 
IFN-c) correlated with increased TLR expression. RLRs were 
upregulated simultaneously. PBMCs of patients with influenza 
showed significant, dynamic changes in their cytokine responses 
upon TLR stimulation, compared with controls.
Conclusions: Our results suggest that TLRs play an important 
role in early, innate viral inhibition in naturally occurring influenza. 
Inflammatory cytokine responses are concomitantly induced. 
These findings support investigation of TLR targeting as a novel 
intervention approach for prophylaxis against influenza.
Ref. No.: 09080102
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Prevention and Treatment of Swine Origin Influenza Virus 
(S-OIV) through the Use of Interferon: An in vivo and ex vivo 
Study
Renee Chan1, Eleanor Fish2, John Nicholls1
1The University of Hong Kong, Hong Kong, 2University of Toronto, 
Toronto, Canada
 
Background:  H1N1pdm infection emerged in 2009 as the 
first influenza pandemic of the 21st century and originated from 
a swine precursor virus. Though this new virus was associated 
with a low mortality compared with seasonal influenza and with 
another new emerging influenza virus (H5N1), the main concerns 
that exist were the mortality in younger patients (contrasting with 
a bias towards elderly patients with seasonal influenza) and the 
potential for this virus to re-assort with avian influenza viruses 
resulting in a highly transmissible virus with a high mortality.
 
Objectives: To determine if prophylactic and/or therapeutic 
administered interferon alpha to ex vivo bronchial and lung tissues 
would be able to reduce H1N1pdm influenza infection.
 
Methods: Fresh bronchial and lung tissues were obtained 
from patients undergoing elective surgery with lobectomy. They 
were cultured with and without interferon and then infected with 
H1N1pdm virus. After 24 and 48 hours incubation the quantity 
of virus produced and the cellular genes involved in the antiviral 
response were analyzed by PCR and by SuperArray.
 
Results: Prophylactic interferon was able to reduce infection with 
H1N1pdm in lung tissues. Therapeutic interferon was beneficial in 
lung tissues but not in bronchial tissues.
 
Conclusions: Exogenous interferon will be useful for pulmonary 
involvement of influenza viruses (H1N1 and H5N1) but may not 
be of significant benefit for bronchial infection.
 
Implications: For influenza virus infections that are resistant 
to currently available antiviral agents, interferon therapy offers 
a potential benefit. This therapy has recently been used in a 
macaque model of H5N1 infection resulting in a decrease in the 
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Profiling of Substrate-Specificity and Rational Design of 
Broad-Spectrum Peptidomimetic Inhibitors for the 3C-Like 
Proteases of Coronaviruses 
Kam-Bo Wong1, Hak-Fun Chow2, David Chi-Cheong Wan3, Chi-
Pang Chuck1, Chao Chen2, Zhihai Ke2
1School of Life Sciences, The Chinese University of Hong Kong, 
Hong Kong, 2Department of Chemistry, The Chinese University 
of Hong Kong, Hong Kong, 3School of Biomedical Sciences, The 
Chinese University of Hong Kong, Hong Kong
Coronaviruses (CoV) are associated with up to 5% of respiratory 
diseases. There are three groups of CoV, namely alphacoronavirus 
(group 1), betacoronavirus (group 2), and gammacoronavirus 
(group 3). Replication of CoV requires an active 3C-like protease 
that processes the viral polyprotein into mature functional 
proteins. Supported by a HMRF grant, our group has profiled the 
substrate specificity of the 3C-like proteases from human CoV 
NL63 (group 1), human CoV OC43 (group 2a), SARS-CoV (group 
2b), and infectious bronchitis virus (IBV; group 3). Based on the 
substrate specificity profile obtained, we have designed a ‘super-
active’ substrate with ~2-3 fold increase in cleavage efficiency. We 
also designed a number of nitrile-based peptidomimetic inhibitors 
and test their inhibitory effects on the 3C-like proteases. The best 
inhibitor, Cbz-AVLQ-CN, was able to inhibit 3C-like proteases 
from a broad spectrum of coronaviruses (human CoV 229E, 
NL63, OC43, HKU1, SARS, and IBV) with IC50 values of 1.3 – 
3.7 mM. Our work provides invaluable insights into the design of 
drugs to combat future outbreak of coronavirus infections.
Ref. No.: 09080282
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Molecular Epidemiological Investigation of PARV4-related 
Viruses in Hong Kong and Southern China
Susanna Kar-pui LAU, Herman TSE, Patrick Chiu-yat WOO, 
Kwok-yung YUEN
The University of Hong Kong, Hong Kong
Introduction: Many emerging infectious diseases are 
zoonoses that cause epidemics in humans after overcoming 
the inter-species barrier. Identifying possible animal origins or 
counterparts of emerging viruses is important in understanding 
their epidemiology, evolution and potential for re-emergence. 
Parvoviruses are widespread pathogens that cause a wide range 
of disease in animals. Human parvovirus 4 (PARV4) was identified 
in 2005, but the epidemiology, mode of transmission, clinical 
significance and origin of this newly identified virus are still poorly 
understood. In particular, unlike the other human parvoviruses 
with related viruses in animals, PARV4 was phylogenetically 
distinct without closely related animal counterparts.
Methods: To identify possible animal origins of PARV4 or related 
viruses, a surveillance study for PARV4-like viruses in human and 
animal samples was conducted. Nearly full-length sequences of 
the identified PARV4-related viruses from sheep, swine, cattle 
and human were determined and analyzed.
Results: PARV4-like viruses were detected by PCR among 
44.4% (148/333) of porcine samples (including lymph nodes, 
liver, serum, nasopharyngeal and fecal samples), 13% (4/32) of 
bovine spleen samples, 1.8% (2/110) of bovine liver samples, 
71.4% (10/14) of ovine spleen samples, 66.7% (6/9) of ovine 
liver samples and 2% (7/362) of human serum samples sent for 
HIV and HCV antibody tests. Four distinct parvoviruses were 
identified, including three novel parvoviruses, ovine hokovirus 
(OHoV), porcine hokovirus (PHoV) and bovine hokovirus (BHoV), 
and PARV4 from humans. Analysis of genome sequences from 
four OHoV, seven PHoV, five BHoV and one PARV4 strains 
showed that the animal parvoviruses were most similar to PARV4 
and together formed a distinct cluster within Parvoviridae. The 
four parvoviruses also differed from other parvoviruses by their 
relatively large predicted VP1 protein and the presence of a small 
unique conserved putative protein. Based on these results, we 
propose a separate genus, Hokovirus, to describe these three 
parvoviruses. The co-detection of porcine reproductive and 
respiratory syndrome virus, the agent associated with the recent 
"high fever" disease outbreaks in pigs in China, from our porcine 
samples warrants further investigations.
Discussion and Conclusions: Three novel parvoviruses, OHoV, 
PHoV and BHoV, were discovered in Hong Kong. Animal viruses 
closely related to PARV-4 were identified in porcine and bovine 
samples, suggesting that interspecies transmission could have 
occurred during their evolution. This has dramatically improved 
the understanding of the origin of PARV-4 and this group of 
novel viruses. Since these animals are common food animals, 
further studies are warranted in studying the pathogenesis and 
epidemiology of these novel parvoviruses.
Ref. No.: 08070712
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Anti-ganglioside Antibodies were not Detected in Human 
Subjects or Mice Infected with or Vaccinated Against 2009 
Pandemic Influenza A (H1N1) Virus
Ting Lei1, Kam-Leung Siu1, Kin-Hang Kok1, Kwok-Hung Chan1, 
Eric Chan2, Ivan Hung1, Kelvin To1, Patrick Li3, Jie Zhou1, Bo-Jian 
Zheng1, Kwok-Yung Yuen1, Ming Wang4, Dong-Yan Jin1
1The University of Hong Kong, Hong Kong, 2Queen Mary Hospital, 
Hong Kong, 3Queen Elezabeth Hospital, Hong Kong, 4Guangzhou 
CDC, Guangzhou, China
Background: Mass vaccination against influenza A virus (H1N1) 
was terminated in USA in 1976 due to significantly increased risk 
of Guillain-Barré syndrome (GBS), an acute, immune-mediated 
demyelinating disorder that can cause paralysis and death. 
Anti-ganglioside antibodies underlying the development of GBS 
were reported by another group to be induced in mice receiving 
an H1N1 vaccine produced in 1976,  another vaccine against 
influenza, or influenza hemaggulutin (HA).
Objectives: The overall goals of this pilot study are to verify the 
ability of swine-origin H1N1 influenza virus HA to induce anti-
ganglioside antibodies in mice and if possible to map the peptide 
sequence associated with this induction. Because human subjects 
infected with or vaccinated against pandemic H1N1 2009 (pdm09) 
were available after the submission and approval of our proposal, 
we also expand our study to analyze anti-ganglioside antibodies 
in individuals infected with or vaccinated against pdm09, including 
eight confirmed cases of post-vaccination GBS. 
Methods: PANFLU.1 vaccine against pdm09 in Freund complete 
adjuvant was used to immunize C57 mice. Serum samples from 
infected or vaccinated human subjects or mice were collected. 
Antibodies against GM1 and other gangliosides were detected by 
commercial ELISA kits. HAI titers in serum samples were also 
analyzed.  
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